REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/04/2025
Voltar para busca
Dado oficial do USPTO
PREDICTSURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PREDICTSURE
ST13
US500000079259194Classe
5, 10, 42, 44
Pedido
79259194
Registro
6039264
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
29/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
18/12/2018
Data de registro
28/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2020
Última transação
29/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BLAZICH,JOAN MICHELE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PredictImmune Ltd.
Representantes
Shoko Naruo Thompson Coburn LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic and prognostic reagents and preparations for medical purposes; diagnostic and prognostic reagents and preparations for laboratory testing for medical purposesincluding laboratory testing of samples from patients
Classe 10
Diagnostic and prognostic apparatusesdevices and instruments for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic test kits comprising test tubestest platesreagents and indicator diagramsfor the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic apparatusesdevices and instruments for medical testing purposes in relation to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis; diagnostic and prognostic test kits comprising test tubestest platesreagents and indicator diagramsfor medical testing purposes in relation to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis
Classe 42
Computer-aided diagnostic and prognostic testing servicesincluding analyzing samples from patients to provide diagnosis and prognosis and guiding treatment optionsmedical laboratory services; software as a service (Saas) services featuring software for diagnosis and prognosis of immune-related diseases; software as a service (SaaS) services featuring software for providing diagnostic or prognostic results and guiding treatment options based on data from patient samples; design and development of diagnostic and prognostic apparatusdeviceskits and instruments; medical and scientific researchdesign and development of diagnostic and prognostic testsincluding diagnostic and prognostic tests relating to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis
Classe 44
Medical servicesincluding diagnostic and prognostic servicesguiding treatment options; RNA and DNA analysisgenetic testing for medical purposes; medical analysis services for the diagnosisprognosis and treatment of persons provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/09/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2020
FIMP
FINAL DISPOSITION PROCESSED
31/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2020
PUBO
PUBLISHED FOR OPPOSITION
11/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/12/2019
RFNP
REFUSAL PROCESSED BY IB
12/07/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/06/2019
RFRR
REFUSAL PROCESSED BY MPU
22/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/06/2019
CNRT
NON-FINAL ACTION WRITTEN
03/06/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/06/2019
DOCK
ASSIGNED TO EXAMINER
28/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PREDICTSURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.